HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study.

AbstractPURPOSE:
In patients with idiopathic pulmonary fibrosis (IPF), hospitalizations are associated with high mortality. We sought to determine in-hospital mortality rates and factors associated with in-hospital mortality in patients with IPF.
METHODS:
Patients with IPF were identified from the Premier Healthcare Database, a representative administrative dataset that includes > 20% of hospital discharges in the US, using an algorithm based on diagnostic codes and billing data. We used logistic regression to analyze associations between patient-, hospital-, and treatment-related characteristics and a composite primary outcome of death during the index visit, lung transplant during the index visit and > 1 day after admission, or death during a readmission within 90 days.
RESULTS:
The cohort comprised 6665 patients with IPF hospitalized between October 2011 and October 2014. A total of 963 (14.4%) met the primary outcome. Factors significantly associated with a higher risk of the primary outcome included mechanical ventilation [odds ratio 4.65 (95% CI 3.73, 5.80)], admission to the intensive care unit [1.83 (1.52, 2.21)], treatment with opioids (3.06 [2.57, 3.65]), and a diagnosis of pneumonia [1.44 (1.21, 1.71)]. Factors significantly associated with a lower risk included concurrent chronic obstructive pulmonary disease [0.65 (0.55, 0.77)] and female sex [0.67 (0.57, 0.79)].
CONCLUSIONS:
Patients with IPF, particularly those receiving mechanical ventilation or intensive care, are at substantial risk of death or lung transplant during hospitalization or death during a readmission within 90 days.
AuthorsMichael T Durheim, Jennifer Judy, Shaun Bender, Dorothy Baumer, Joseph Lucas, Scott B Robinson, Omar Mohamedaly, Bimal R Shah, Thomas Leonard, Craig S Conoscenti, Scott M Palmer
JournalLung (Lung) Vol. 197 Issue 6 Pg. 699-707 (12 2019) ISSN: 1432-1750 [Electronic] United States
PMID31541276 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics, Opioid
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Analgesics, Opioid (therapeutic use)
  • Cohort Studies
  • Comorbidity
  • Female
  • Hospital Mortality
  • Humans
  • Idiopathic Pulmonary Fibrosis (epidemiology, mortality, therapy)
  • Intensive Care Units
  • Logistic Models
  • Lung Transplantation (statistics & numerical data)
  • Male
  • Middle Aged
  • Patient Readmission (statistics & numerical data)
  • Pneumonia (epidemiology)
  • Protective Factors
  • Pulmonary Disease, Chronic Obstructive (epidemiology)
  • Respiration, Artificial
  • Risk Factors
  • Sex Factors
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: